BRUSSELS, Belgium, May 7 /PRNewswire/ --

The Brattle Group has proposed guidelines for the sound economic regulation of energy suppliers and recommended incentives for suppliers to help encourage energy efficiency and cost savings throughout the industry. This issue has received increased attention over the past year, especially after last December's United Nations Climate Change Conference in Bali.

WATERLOO, Canada, May 7 /PRNewswire/ -- You are invited to view an important, live webcast announcement by Mike Lazaridis, Chairman of the Board of Directors of Perimeter Institute for Theoretical Physics (PI), regarding the appointment of a new Executive Director - an internationally respected scientist of the highest order who will lead PI in the next, exciting phase of development.

SAN FRANCISCO and NEW YORK, May 7 /PRNewswire/ --

- NGN Capital leads US$12 Million in Series A First Tranche Financing

NGN Capital announced today the formation of ACT Biotech Inc., a new company dedicated to developing and commercializing targeted oral cancer drugs. ACT Biotech has entered into a license agreement with Bayer HealthCare LLC for a portfolio of clinical and early stage oncology assets. In conjunction with the agreement, ACT has raised US$12 million in the first tranche of a Series A financing led by NGN Capital, New York. The company has also now initiated the syndication process to raise a total of US$20 million, expected to be completed in the second quarter of 2008.

ABBOTT PARK, Illinois, May 7 /PRNewswire/ --

- Phase II Data Demonstrate Abbott's Most Advanced NNR Candidate ABT-089 Shows Strong Safety, Tolerability And Efficacy in Adults With ADHD

Abbott (NYSE: ABT) and other leading scientists will present new Phase II data showing that ABT-089, a selective neuronal nicotinic receptor (NNR) agonist, is a potentially effective and safe treatment for adults with Attention-Deficit Hyperactivity Disorder (ADHD). The studies are being presented today at the American Psychiatric Association (http://www.psych.org/) 161st Annual Meeting in Washington, D.C.

Rensselaer Polytechnic Institute graduating senior Jeffery Martin has put his basic knowledge of sugars to exceptional use by creating a lab-on-a-chip device that builds complex, highly specialized sugar molecules, mimicking one of the most important cellular structures in the human body - the Golgi Apparatus.

Among the most important and complex molecules in the human body, sugars control not just metabolism but also how cells communicate with one another.

Cells build sugars in a cellular organelle known as the Golgi Apparatus. Under a microscope, the Golgi looks similar to a stack of pancakes. The strange-looking organelle finishes the process of protein synthesis by decorating the proteins with highly specialized arrangements of sugars. The final sugar-coated molecule is then sent out into the cell to aid in cell communication and to help determine the cell’s function in the body.

CALGARY, Canada, May 7 /PRNewswire/ -- Addax Petroleum Corporation ("Addax Petroleum" or the "Corporation") (TSX: AXC and LSE: AXC), announces that Mr. Jean Claude Gandur, President and Chief Executive Officer, will be presenting at the Tristone Capital Energie'08 Conference in Paris on Tuesday May 13th, 2008 at approximately 2:55 p.m. local time (1:55 p.m. London U.K. Time / 8:55 a.m. Eastern Time).

Investors are invited to use the link below to watch the presentation and listen to the live audio cast. To enroll for the event, click on the Large Cap E+P box and then click "Enroll". Follow-up emails will indicate how to join the event.

https://tristonecapital-ls.webex.com/tristonecapital-ls/onstage/g.php?p=...

SAO PAULO, Brazil, May 7 /PRNewswire/ --

BRASKEM S.A. (BOVESPA: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK), the leading company in the thermoplastic resins industry in Latin America and third-largest resins producer in the Americas, announces today its results for the first quarter of 2008 (1Q08).

Main highlights of the period: -- Domestic resin sales grew 7% in 1Q08 -- Resins production reached 704,000 tons in 1Q08 -- Fixed expenses reduction in 1Q08 -- Over R$77 million in synergies captured until 1Q08 -- EBITDA reaches R$583 million in 1Q08 -- Braskem inaugurates Paulinia unit -- Conclusion of the acquisition of the petrochemical assets of the Ipiranga Group -- Conclusion of sale of its stake at Petroflex -- Green Polymer Project moves forward

TORONTO, May 7 /PRNewswire/ -- Apotex Inc., Canada's largest generic pharmaceutical company has successfully bid and been awarded a tender from the Rwandan Government for the life saving triple combination AIDS drug "Apo Triavir". Apotex is the first company to provide this medicine to Africa under the provisions of the Canadian Access to Medicines Regime (CAMR).

The CAMR provides a mechanism for developing countries to address critical healthcare needs by importing less expensive generic versions of patented drugs. Following the process it has taken Apotex over three years to get to this point where a drug can go to thousands in Africa.

SAN DIEGO, May 7 /PRNewswire/ --

- New Member Complements Board With Significant Financial and Operational Expertise -

Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today the appointment of John Varian to the company's board of directors. Mr. Varian currently serves as the chief operating officer and chief financial officer of Aryx Therapeutics, a pharmaceutical company focused on the discovery and development of oral therapeutics for chronic disease.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080303/LAM023LOGO)

LONDON, May 7 /PRNewswire/ --

- Astadia Gains Momentum in 2008 and Continues Providing SaaS Solutions to Assist Collaboration Across Teams and Organisations